# Arthrocentesis Versus Botulinum Toxin Injection in Patients With Temporomandibular Joint Disorders: A Randomized Controlled Trial

> **NCT07736521** · NA · NOT_YET_RECRUITING · sponsor: **Mudher MB Alsunbuli** · enrollment: 66 (estimated)

## Conditions studied

- Temporomandibular Joint Disorders
- Temporomandibular Joint Dysfunction Syndrome
- Facial Pain

## Interventions

- **PROCEDURE:** Arthrocentesis
- **DRUG:** Botulinum Toxin-A

## Key facts

- **NCT ID:** NCT07736521
- **Lead sponsor:** Mudher MB Alsunbuli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-15
- **Primary completion:** 2026-11-15
- **Final completion:** 2027-05-01
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736521, "Arthrocentesis Versus Botulinum Toxin Injection in Patients With Temporomandibular Joint Disorders: A Randomized Controlled Trial". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07736521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*